Skip to main content
Equibles
SDGR logo

SDGR · Schrodinger, Inc. · Metrics

Track SDGR — free

Use SDGR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SDGR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.61 -0.16 (-0.56%) Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.13B
Shares
75.08M
Volume · Nov 5 2.22M Avg daily vol (3M) 2.01M

SDGR metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.77
Market cap
$2.13B

Price action

20 metrics
Price change (1W)
-7.6%
Price change (30D)
-1.3%
Price change (3M)
+73.9%
Price change (6M)
+119.7%
Price change (YTD)
+59.5%
Price change (1Y)
+42.7%
Trailing year
Price change (5Y)
-51.6%
52-week high
$32.60
52-week low
$11.07
Change from 52-week high
-12.5%
Change from 52-week low
+157.6%
Annualized volatility
66.0%
Annualized volatility (3M)
96.7%
Beta
1.8
RSI (14D)
56.3
Price vs SMA 50
+12.2%
Price vs SMA 200
+68.6%
Avg volume (3M)
2.01M
Relative volume
1.0
Average dollar volume
$52.06M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
75.08M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
6.6×
reciprocal yield 15.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
7.9×
reciprocal yield 12.6%
P / book
7.1
reciprocal yield 14.1%
FCF yield
-5.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
96.8×
reciprocal yield 1.0%
P / E historical average (5Y)
96.8×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.4%
EV / revenue historical average (5Y)
7.6×
reciprocal yield 13.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
58.5%
Operating margin
-49.6%
Trailing 12 months
Net margin
-22.0%
Gross profit (TTM)
$157.53M
Operating profit (TTM)
−$133.63M
Net income (TTM)
−$59.25M
Trailing 12 months
Diluted EPS (TTM)
$-0.78
FCF margin
-43.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.61
Gross profit per diluted share (TTM)
$2.12
Operating profit per diluted share (TTM)
$-1.79
EBITDA per diluted share (TTM)
$-1.71
Net income per diluted share (TTM)
$-0.79
Operating cash flow per diluted share (TTM)
$-1.50
Free cash flow per diluted share (TTM)
$-1.56
Capital expenditures per diluted share (TTM)
$0.06
R&D per diluted share (TTM)
$2.15
Stock compensation per diluted share (TTM)
$0.48
Book value per share
$8.71

Growth

11 metrics
Revenue growth YoY
+18.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$269.20M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+12.2%
Revenue CAGR (5Y)
+18.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-2.6%

Quality

14 metrics
Return on equity
-19.6%
Return on assets
-9.7%
Debt / equity
0.0
Current ratio
2.7
EBITDA (TTM)
−$127.77M
Free cash flow (TTM)
−$116.77M
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$366.36M
Latest balance sheet
Cash & equivalents
$246.98M
Total assets
$611.94M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$112.58M
Capital expenditures (TTM)
$4.20M
R&D (TTM)
$160.31M
SG&A (TTM)
—
Stock compensation (TTM)
$35.75M
R&D / revenue
59.6%
Stock compensation / revenue
13.3%

Ownership (13F)

9 metrics
13F filers
234
13F filer change QoQ
+3
Institutional ownership
87.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-4.5%
Holder tenure
14.9
Price vs estimated holder cost
-26.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.2%

Short interest

3 metrics
Short interest
13.9%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
84 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$927,970
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1490978 CUSIP 80810D103 13F (30d) 119 filings 103 filers Visit website Investor relations